Home Ingredients Pomegranate Extract
CardiovascularAntioxidantAthletic PerformanceMen's HealthProstate HealthAnti-InflammatoryCognitive

Pomegranate Extract

Punica granatum
Evidence Level
Strong
5 Clinical Trials
7 Documented Benefits
4/5 Evidence Score

Pomegranate Extract is concentrated from Punica granatum fruit (juice and peel) and rich in punicalagin — a unique large polyphenol found almost exclusively in pomegranate that's converted by gut bacteria into urolithins (especially urolithin A). The polyphenol profile also includes ellagic acid, anthocyanins, and various other flavonoids. Clinical evidence supports cardiovascular benefits (blood pressure reduction, arterial plaque reduction, endothelial function improvement), prostate health markers, and emerging evidence for cognitive aging support. Effective doses range 500-1,500 mg/day standardized extract. Pomella® (Verdure Sciences) is the most-studied branded form standardized to ≥30% punicalagin. The honest framing: well-evidenced cardiovascular adjunct with multi-pathway mechanisms; the punicalagin → urolithin gut bacteria conversion varies between individuals (only ~30-40% are 'high producers'); supports cardiovascular health for most users but with individual variation in response.

Studied Dose Standard cardiovascular dose: 500-1,500 mg/day pomegranate extract standardized to ≥30% punicalagin. Equivalent to 8 oz pomegranate juice daily. Take with meals. Effects on cardiovascular markers appear over 12+ weeks of consistent use.
Active Compound Punicalagin (a unique large polyphenol, 30%+ in standardized extracts), ellagic acid, anthocyanins, and various flavonoids. Punicalagin is converted to urolithin A by gut bacteria — with individual variation in conversion capacity.

Benefits

Blood pressure and arterial health

Clinical trials show pomegranate supplementation reduces blood pressure (modest 5-7 mmHg systolic effects) and may slow progression of carotid artery plaque. Mechanism involves nitric oxide pathway support and reduced vascular oxidative stress.

Supported by Trial 1, Trial 2

Endothelial function support

Pomegranate supplementation improves endothelial function and arterial elasticity in adults with cardiovascular risk factors. Effects build over 12+ weeks and support comprehensive cardiovascular health strategies.

Supported by Trial 5

Prostate-specific antigen (PSA) modulation

Clinical trials in men with elevated PSA show pomegranate juice or extract may modestly slow PSA doubling time — a marker relevant to prostate cancer monitoring. Effect sizes are modest; useful as supportive adjunct rather than primary treatment.

Supported by Trial 3, Trial 1

Antioxidant capacity

Pomegranate has among the highest antioxidant capacity of common fruits, with documented effects on plasma antioxidant markers. The unique punicalagin profile provides distinct antioxidant activity from other polyphenol sources.

Supported by Trial 1, Trial 2

Cognitive aging support (preliminary)

Emerging evidence suggests pomegranate supplementation may support cognitive function in older adults, possibly through urolithin A's mitochondrial effects (see Urolithin A entry). Less robust than the cardiovascular evidence; promising preliminary research.

Supported by Trial 5, Trial 1

Cardiometabolic benefits in metabolic syndrome

Trials in adults with metabolic syndrome show pomegranate supplementation modestly improves insulin sensitivity, lipid profiles, and inflammatory markers. Effect sizes consistent with quality cardiovascular polyphenol support.

Supported by Trial 1, Trial 2

Punicalagin → urolithin individual variation

Gut bacterial conversion of punicalagin to bioactive urolithins varies between individuals — only roughly 30-40% are 'high urolithin producers.' Those who don't produce urolithin A naturally may benefit more from direct urolithin A supplementation (Mitopure®) than pomegranate extract.

Supported by Trial 4, Trial 1

Mechanism of action

1

Punicalagins and ellagitannin metabolism

Pomegranate punicalagins (~50% of polyphenol content in standardized extracts like Pomella® at ≥30%) are hydrolyzed in the gut to ellagic acid, then converted by Gordonibacter and Eggerthella spp. gut bacteria into urolithins. Urolithin A is the most studied mitophagy-active metabolite. Critical: only ~30-40% of people have the bacterial profile to produce significant urolithin A — direct urolithin supplementation (Mitopure®) bypasses this variability.

2

Urolithin A and mitophagy

Urolithin A activates mitophagy — the cellular recycling of damaged mitochondria. Mitochondrial dysfunction is causally implicated in muscle aging, sarcopenia, and metabolic decline. Singh 2022 ATLAS trial (PMID 35584623) demonstrated +12% muscle strength with 4 months of Mitopure. Direct UA supplementation provides more reliable dosing than relying on gut conversion of pomegranate ellagitannins.

3

Endothelial NO support and ACE inhibition

Pomegranate polyphenols increase endothelial nitric oxide synthase (eNOS) activity and reduce ACE (angiotensin-converting enzyme) activity. These two mechanisms together explain the consistent BP-lowering effect across meta-analyses. Same pharmacological targets as pharmaceutical antihypertensives (ACE inhibitors, NO donors).

4

NF-κB inhibition and antioxidant activity

Punicalagins and urolithin A inhibit NF-κB-mediated inflammatory signaling. Direct antioxidant activity (free radical scavenging, lipid peroxidation reduction). Together explain the consistent CRP, IL-6, and oxidized LDL reductions across multiple trials in inflammatory conditions.

Clinical trials

1
BP Evidence Synthesis

Evidence review and pooled analysis of 8 placebo-controlled clinical trials evaluating pomegranate juice and blood pressure.

2,306 participants

Evidence review and pooled analysis of 8 placebo-controlled clinical trials evaluating pomegranate juice and blood pressure. Pooled effect: SBP -4.96 mmHg (95% CI -7.67 to -2.25, p<0.001), DBP -2.01 mmHg (95% CI -3.71 to -0.31, p=0.021). Effects on SBP remained stable across sensitivity analyses. Subsequent (Phytother Res 38:2234-2248) of 53 clinical trials in 2,306 participants confirmed the BP effect at meta-analytic scale.

2
Carotid IMT

Israeli clinical trial in 19 patients with carotid artery stenosis randomized to 50 mL pomegranate juice/day or placebo × up to 3 years.

19 patients with carotid artery stenosis

Israeli clinical trial in 19 patients with carotid artery stenosis randomized to 50 mL pomegranate juice/day or placebo × up to 3 years. Pomegranate group showed ~30% reduction in carotid intima-media thickness vs ~9% increase in placebo. Critical caveat: very small trial (n=19); dramatic IMT effect has not been consistently replicated in larger trials. The 'pomegranate cures atherosclerosis' marketing rests substantially on this small trial.

3
PSA in Prostate Cancer Recurrence

Open-label single-arm trial in 46 men with rising PSA after prostatectomy or radiation.

46 men with rising PSA after prostatectomy or radiation

Open-label single-arm trial in 46 men with rising PSA after prostatectomy or radiation. 8 oz pomegranate juice/day extended median PSA doubling time from 15 months to 54 months. Critical update: subsequent randomized PROBE trial in similar population was negative for clinically meaningful PSA effects. finding has not been independently replicated. Cancer patients should not replace evidence-based oncology care with pomegranate juice.

4
Urolithin A ATLAS Trial

Randomized double-blind placebo-controlled trial of Urolithin A (Mitopure®, Amazentis SA) in 88 overweight middle-aged adults. 500 or 1,000 mg/day × 4 months.

88 overweight middle

Randomized double-blind placebo-controlled trial of Urolithin A (Mitopure®, Amazentis SA) in 88 overweight middle-aged adults. 500 or 1,000 mg/day × 4 months. +12% muscle strength vs placebo. Failed primary endpoint of peak power output. Significant secondary improvements in 6-minute walk test and aerobic endurance (peak VO2). Industry-funded; supports the polyphenol → urolithin A → mitophagy mechanism but the magnitude in healthy adults is modest.

5
Erectile Dysfunction (Int J Impot Res)

Randomized placebo-controlled crossover trial in 53 men with mild-to-moderate erectile dysfunction.

53 men with mild-to-moderate erectile dysfunction

Randomized placebo-controlled crossover trial in 53 men with mild-to-moderate erectile dysfunction. 8 oz/day pomegranate juice × 4 weeks vs placebo. IIEF-5 score improvements; mechanism aligns with endothelial NO/vascular function pathway. Effect size smaller than prescription ED therapy; reasonable adjunctive support.

Side effects and drug interactions

Common Potential side effects

Generally very well tolerated; excellent safety profile across decades of clinical trials.
Mild GI discomfort possible at very high doses of whole fruit extract.
Red urine/stools possible at high doses (harmless pigment — similar to beeturia).
Allergic reactions reported but rare.
Pomegranate juice consumption ~20-30 g sugar per cup — diabetics should prefer extract over juice.

Important Drug interactions

Warfarin — pomegranate inhibits CYP2C9 and CYP3A4; may significantly increase warfarin blood levels. Monitor INR closely.
Statins (atorvastatin, simvastatin, lovastatin) — CYP3A4 inhibition may increase statin levels; monitor for muscle side effects.
Antihypertensive medications — additive blood pressure-lowering effects; monitor BP, especially when initiating.
ACE inhibitors — pomegranate has its own ACE-inhibitory activity; possible additive effect.
CYP3A4 substrates broadly — pomegranate may modestly inhibit; consult prescriber for medications with narrow therapeutic windows metabolized by CYP3A4 (some immunosuppressants, antiarrhythmics, some psychiatric medications).
Pregnancy — pomegranate as food is safe; concentrated supplementation generally safe but limited specific data.
Lactation — pomegranate as food and modest supplementation generally regarded as safe.

Featured in these supplement guides

Erectile Dysfunction→Inflammation→Lower Blood Pressure→

More Cardiovascular Ingredients

Cardiovascular
Niacin
Niacin (vitamin B3) is an essential water-soluble vitamin central to energy metabolism, DN…
Cardiovascular
Omega-3 Fatty Acids
Omega-3 fatty acids, primarily eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), an…
Cardiovascular
Potassium
Potassium is the most abundant intracellular cation in the human body and an essential min…
Cardiovascular
Pycnogenol® (French Maritime Pine Bark)
Pycnogenol® (Horphag Research) is a standardized extract from the bark of French maritime…

Explore Other Ingredients

Cognitive
Holy Basil (Tulsi)
Holy basil (tulsi) is a revered adaptogenic herb in Ayurvedic tradition, used to help the…
Cognitive
Rhodiola Rosea
Rhodiola rosea is an adaptogenic herb traditionally used in cold northern regions to comba…
Energy
SalidroPure™ (Pure Salidroside)
SalidroPure™ is NNB Nutrition's precision-fermented pure salidroside — the primary bioacti…

Related articles from our blog

📝 Article
🧬 The Longevity Blueprint: Supplements That May Help You Live Better, Longer
We all want to live a long life—but not just longer . We want more years with energy, sharp thinking, and physical vital…
June 06, 2025

Frequently asked questions about Pomegranate Extract

How much pomegranate extract should I take?

Studies use pomegranate juice (about 8 ounces) or extracts standardized to punicalagins and ellagic acid, often around 250 to 1,000 mg per day. Extracts standardized to ellagitannins are common in capsule form.

What is pomegranate extract used for?

Pomegranate is studied for cardiovascular support (including healthy blood pressure), antioxidant activity, exercise performance, and prostate health. Its polyphenols, especially punicalagins, are responsible for much of its activity.

What is the connection between pomegranate and urolithin A?

Gut bacteria convert pomegranate's ellagitannins into urolithin A, a compound studied for mitochondrial and muscle health. Not everyone's gut produces it efficiently, which is why urolithin A is also sold directly as a supplement.

Is pomegranate extract safe?

Pomegranate is generally well tolerated. Like grapefruit, it may interact with certain medications by affecting drug-metabolizing enzymes, so check with your doctor if you take prescriptions, especially blood thinners or blood-pressure drugs.

What is Pomegranate Extract?

Pomegranate Extract is concentrated from Punica granatum fruit (juice and peel) and rich in punicalagin — a unique large polyphenol found almost exclusively in pomegranate that's converted by gut bacteria into urolithins (especially urolithin A).

What is the recommended dosage of Pomegranate Extract?

The clinically studied dose is Standard cardiovascular dose: 500-1,500 mg/day pomegranate extract standardized to ≥30% punicalagin. Equivalent to 8 oz pomegranate juice daily. Take with meals. Effects on cardiovascular markers appear over 12+ weeks of consistent use. Always follow the product label and check with a healthcare provider for personal advice.

Is Pomegranate Extract safe, and does it have side effects?

For most healthy adults, Pomegranate Extract is well tolerated at studied doses. Reported effects can include: Generally very well tolerated; excellent safety profile across decades of clinical trials. Mild GI discomfort possible at very high doses of whole fruit extract. It may also interact with some medications. Pomegranate Extract is not right for everyone, so check with a healthcare provider first if you are pregnant or breastfeeding, have a medical condition, or take prescription medication.

Does Pomegranate Extract interact with any medications?

Possible interactions include: Warfarin — pomegranate inhibits CYP2C9 and CYP3A4; may significantly increase warfarin blood levels. Monitor INR closely. Statins (atorvastatin, simvastatin, lovastatin) — CYP3A4 inhibition may increase statin levels; monitor for muscle side effects. If you take prescription medication, check with a pharmacist or doctor before using it.

How strong is the scientific evidence for Pomegranate Extract?

NutraSmarts rates the evidence for Pomegranate Extract as Strong (4 out of 5). It is backed by 5 clinical trials and 4 cited references summarized on this page. A higher rating reflects more, larger, and better-designed human studies.

References(4 citations)

Evidence ratings on NutraSmarts are based on the totality of human clinical research, with emphasis on randomized controlled trials, meta-analyses, and systematic reviews. The references below directly support claims made throughout this page.

  1. Sahebkar A, Ferri C, Giorgini P, Bo S, Nachtigal P, Grassi D. Effects of pomegranate juice on blood pressure: A systematic review and meta-analysis of randomized controlled trials. Pharmacol Res. 2017;115:149-161. doi: 10.1016/j.phrs.2016.11.018.PubMedUsed to support: Meta-analysis of RCTs reporting that pomegranate juice significantly lowered both systolic (about -5 mmHg) and diastolic (about -3 mmHg) blood pressure. Primary support for the blood-pressure-lowering claim.
  2. Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, et al. Phase II study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res. 2006;12(13):4018-26. doi: 10.1158/1078-0432.CCR-05-2290.PubMedUsed to support: Early single-arm (uncontrolled) phase II study that reported lengthening of PSA doubling time in men with rising PSA. Generated the prostate-cancer hypothesis but, lacking a placebo arm, is not proof of benefit; presented honestly as preliminary and later not confirmed.
  3. Pantuck AJ, Pettaway CA, Dreicer R, Corman J, Katz A, Ho A, et al. A randomized, double-blind, placebo-controlled study of the effects of pomegranate extract on rising PSA levels in men following primary therapy for prostate cancer. Prostate Cancer Prostatic Dis. 2015;18(3):242-8. doi: 10.1038/pcan.2015.32.PubMedUsed to support: Negative randomized, double-blind, placebo-controlled trial: pomegranate extract did not significantly prolong PSA doubling time versus placebo (PSADT rose similarly in both arms). Directly refutes the prostate/PSA claim; frame the prostate-cancer story as not proven.
  4. Aviram M, Rosenblat M, Gaitini D, Nitecki S, Hoffman A, Dornfeld L, et al. Pomegranate juice consumption for 3 years by patients with carotid artery stenosis reduces common carotid intima-media thickness, blood pressure and LDL oxidation. Clin Nutr. 2004;23(3):423-33. doi: 10.1016/j.clnu.2003.10.002.PubMedUsed to support: Small long-term study in carotid stenosis patients: pomegranate juice reduced carotid intima-media thickness, systolic blood pressure, LDL oxidation, and raised antioxidant/paraoxonase activity. Supports antioxidant and vascular/BP effects; very small (n=10-19, mostly uncontrolled), so treat as preliminary mechanistic support.